Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

367 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Performance of CT Compared with 18F-FDG PET in Predicting the Efficacy of Nivolumab in Relapsed or Refractory Hodgkin Lymphoma.
Mokrane FZ, Chen A, Schwartz LH, Morschhauser F, Stamatoullas A, Schiano de Colella JM, Vercellino L, Casasnovas O, Chauchet A, Delmer A, Nicolas-Virelizier E, Ghesquières H, Moles-Moreau MP, Schmitt A, Duléry R, Bouabdallah K, Borel C, Touati M, Deau-Fischer B, Peyrade F, Seban RD, Manson G, Houot R, Dercle L. Mokrane FZ, et al. Radiology. 2020 Jun;295(3):651-661. doi: 10.1148/radiol.2020192056. Epub 2020 Apr 14. Radiology. 2020. PMID: 32286191
Using a single abdominal computed tomography image to differentiate five contrast-enhancement phases: A machine-learning algorithm for radiomics-based precision medicine.
Dercle L, Ma J, Xie C, Chen AP, Wang D, Luk L, Revel-Mouroz P, Otal P, Peron JM, Rousseau H, Lu L, Schwartz LH, Mokrane FZ, Zhao B. Dercle L, et al. Among authors: chen ap. Eur J Radiol. 2020 Apr;125:108850. doi: 10.1016/j.ejrad.2020.108850. Epub 2020 Jan 28. Eur J Radiol. 2020. PMID: 32070870 Free PMC article.
A phase 1 study of orally administered 5-fluoro-2'-deoxycytidine with tetrahydrouridine in patients with refractory solid tumors.
Chen AP, Kummar S, Rubinstein L, Zlott J, Coyne GO, Chung V, Newman EM, Lenz HJ, Kelly K, Villaruz LC, Konaté MM, Ferry-Galow KV, Wang L, Kinders RJ, Parchment RE, Covey JM, Holleran JL, Piekarz RL, Miller SB, Juwara L, Beumer JH, Doroshow JH. Chen AP, et al. Cancer Chemother Pharmacol. 2025 Dec 22;96(1):1. doi: 10.1007/s00280-025-04844-y. Cancer Chemother Pharmacol. 2025. PMID: 41428220 Free PMC article. Clinical Trial.
Phase 1 study evaluating the safety, preliminary efficacy, and pharmacodynamics of recombinant interleukin-15 in combination with nivolumab and ipilimumab in patients with refractory cancers.
Ahmed J, O'Sullivan Coyne G, Rubinstein LV, Shin SJ, Takebe N, Bruns A, Augustine B, Mukherjee J, Ma N, Fino K, Fung KL, Ferry-Galow KV, Johnson BC, Parchment RE, Streicher H, Doroshow JH, Chen AP. Ahmed J, et al. Among authors: chen ap. J Immunother Cancer. 2025 Dec 21;13(12):e013252. doi: 10.1136/jitc-2025-013252. J Immunother Cancer. 2025. PMID: 41423268 Free PMC article. Clinical Trial.
367 results